when will eli lilly release retatrutide just released impressive study results for retatrutide, an investigational weight loss drug that targets three hormones—and may deliver more weight loss than current GLP-1s. See link below ⬇️ When will Retatrutide be available

Gu et al., 2013

Written by: Anela Martinovi, PhD, together with Gali Artzi, PhD, Eva Everloo, Nurit Ben, & Taire Brown The Rise of GLP-1 Just a few short years ago, the term GLP-1 or Ozempic would have meant little to the average person

It takes a few minutes and helps our clinical team recommend the safest and most effective treatment plan

The FDA has approved Wegovy and Zepbound for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

Most people with this condition cant get around well

Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, et al